« Back
Home /
Nivolumab Biosimilar(Anti-PDCD1 / PD-1 / CD279 Reference Antibody)

Nivolumab Biosimilar(Anti-PDCD1 / PD-1 / CD279 Reference Antibody)

Item no.	DCC-A014-10mg
Manufacturer	DCChemicals
CASRN	946414-94-4
Amount	10 mg
Quantity options	100 mg 10 mg 25 mg
Category	Reagents & Chemicals Molecules
Type	Chemicals
Specific against	other
Smiles	S(C)(C=CC(C)CC(C1=CC=CC2=C1NC(C)(C)CC2C)=O)(=O)=O.S(C)(C=CCCC(C1=CC=CC2=C1NC(C)(C)CC2C)=O)(=O)=O.S(C)(C=CC(C)CC(C1=CC=CC2C(C)=CC(C)(C)NC=21)=O)(=O)=O.S(C)(C=CCCC(C1=CC=CC2C(C)=CC(C)(C)NC=21)=O)(=O)=O
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	946414-94-4
Similar products	946414-94-4
Available
Manufacturer - Applications	Nivolumab anti-PD-1) is a genetically engineered fully human immunoglobulin Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1PD-1PCD-1) with immune checkpoint inhibitory and antineoplastic activities.
Manufacturer - Category	Therapeutic Antibodies
Molecular Weight	1365.86541652679

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10 mg

available

Delivery expected until 1/1/2026

Express Delivery: Save 6 days

Compare

Add to wishlist

Get an offer